Lower Urinary Tract Symptoms (LUTS): The Role of Medications in Improvement of Quality of Life

The document discussed the treatment of lower urinary tract symptoms (LUTS), which affected nearly half of men in their 50s, impacting their quality of life and daily activities. The primary cause was often related to the prostate, though prostate size did not directly correlate with symptom severity. The focus of LUTS therapy was on improving quality of life, preventing complications, and reducing surgical interventions, which had decreased due to effective drug therapies. Various medications were used, including alpha 1 blockers, 5 alpha-reductase inhibitors, muscarinic receptor antagonists, PDE 5 inhibitors, and beta 3 agonists, with combination therapy being common to address specific symptoms.